Lighthouse Pilot Product
Not Specified
PilotLaunched 2020
Key Facts
About Cipherome
Founded in 2015 in Silicon Valley, Cipherome aims to accelerate precision medicine by simplifying complex healthcare data analysis. The company has evolved from a pharmacogenomics focus to offering the COMPASS platform, a comprehensive tool for clinical research, genomic analysis, and AI model training. Cipherome has conducted clinical validation studies with prestigious institutions and is actively commercializing its platform while contributing to healthcare data science education.
View full company profileTherapeutic Areas
Other Not Specified Drugs
| Drug | Company | Phase |
|---|---|---|
| Inflammation Programs | Arcus Biosciences | Not Specified |
| Bone Marrow Conditioning Program | Telix Pharmaceuticals | Pipeline |
| AGMB-447 | Agomab Therapeutics | Not Disclosed |
| AGMB-101 | Agomab Therapeutics | Not Disclosed |
| TRIFERTY-ATM® | Laboratorio Reig Jofre | Approved/Commercial |
| AGEN1571 (anti-ILT2) | Agenus | Not specified |
| AGEN1777 | Agenus | Not specified |
| AGEN1721 | Agenus | Not specified |
| INCAGN1876 (GITR Agonist) | Agenus | Not specified |
| INCAGN1949 (OX40 Agonist) | Agenus | Not specified |
| AGEN1327 (anti-TIGIT) | Agenus | Not specified |
| AGEN2373 (CD137 Agonist) | Agenus | Not specified |